Healthpeak Properties: Buy Reaffirmed As Outpatient And Senior Portfolio Shows Proven Performance

Healthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro environment, dividend coverage and high yield, an investment-grade rating, and leasing growth in Q2. Selective diversification is spread across outpatient, lab, and senior housing across a geographically diverse scale. Further growth is underpinned by a recent joint venture with Brookfield Asset Management. Sector risks like supply/demand, peer consolidation/mergers, and earnings trends were also discussed. A +$14B Healthcare REIT with 4 Earnings Beats in a Row As it's October soon, today's coverage of Healthpeak Properties ( DOC ) is in effect a 1-year anniversary article, and notably, the stock has seen a total return